Private Equity

Managers

Kleiner Perkins, Shasta Ventures make about 20x their money on Nest Labs - Reuters

Jan 14 (Reuters) - Kleiner Perkins Caufield & Byers has made a return of 20 times on the $20 million it invested in Nest Labs over the years following the company’s sale to Google Inc in a $3.2 billion deal, a person familiar with the situation told affiliated news service Reuters.

4 min read · 14 January 2014

Kleiner Perkins, Shasta Ventures make about 20x their money on Nest Labs

The two VC firms were investors in the company, which Google has acquired in a $3.2 billion deal

4 min read · 14 January 2014

ff Venture Capital raises $52 mln for third fund

According to a blog post on its site, New York-based early-stage VC firm ff Venture Capital said Tuesday that it has closed $52 million for its third fund that was originally targeted at $50 million. The pool's new LPs include New York State’s Empire State Development, Goldman Sachs and the New Jersey Economic Development Authority. According to the firm, the fund will focus on "game-changing ideas and businesses" as well as current portfolio companies that are growing and doing well.

1 min read · 14 January 2014

U.S. venture funds raise more in fourth quarter, but less for year - Reuters

Jan 13 (Reuters) - U.S. venture funds raised $4.85 billion last quarter, up 53 percent from the same period a year ago, but full-year 2013 fundraising fell 15 percent compared to the year before.

1 min read · 13 January 2014

Cancer-focused biotech accelerator Triphase launched by FACIT and MaRS

Triphase Accelerator Corp, a cancer-focused biotechnology accelerator, has been formed by an investment partnership of Fight Against Cancer Innovation Trust (FACIT) and affiliates of commercialization and innovation hubs MaRS Innovation and MaRS Discovery District. With operations in Toronto and San Diego, Calif., Triphase aims to support differentiated products through proof of concept (Phase II) faster and more efficiently. Originally spun out of the Ontario Institute for Cancer Research in 2010, Triphase has entered into a strategic relationship with Celgene Corp, a manufacturer of drug therapies for cancer and inflammatory disorders with headquarters in Summit, New Jersey.

4 min read · 13 January 2014

2013 slowest year of VC fundraising since 2010 - Reuters and NVCA

According to data compiled by Thomson Reuters and the National Venture Capital Association, U.S. VC firms raised a total of $4.9 billion from 48 funds during the final quarter of 2013. This figure represents an increase of 12 percent as compared to the previous quarter as well as a 53 percent increase from the same period in 2012. However, the number of funds plunged to 21 percent versus the third quarter of 2013. Also, Thomson Reuters and NVCA reported that VC firms closed a total of $16.7 billion from 185 funds during 2013, a 15 percent drop compared to 2012. Overall, 2013 was the slowest year of fundraising since 2010.

5 min read · 13 January 2014

Plymouth Ventures raises $31.6 for third fund - VentureWire

According to VentureWire, the Ann Arbor, Michigan-based Plymouth Ventures has received $31.6 for its third fund. The pool's target is $80 million.

1 min read · 13 January 2014

Data spotlight: America’s venture deserts

Six states that are raising few dollars relative to their potential

4 min read · 13 January 2014

Fund performance: OPERS’ growth spurt with venture capital

The state pension manager has invested in eight funds in the past four years

2 min read · 13 January 2014

Capitulation index: Looking for opportunity where VCs hate to tread

With the the J.P. Morgan Healthcare Conference kicking off this week, we look at what other sectors in addition to healthcare could be poised to bounce back

3 min read · 13 January 2014

Showing 8,761 to 8,770 of 19,691 results
1…876878…1000